Anti AChR antibody: relevance to diagnosis and clinical aspects of myasthenia gravis
- PMID: 3397267
- DOI: 10.1007/BF02337460
Anti AChR antibody: relevance to diagnosis and clinical aspects of myasthenia gravis
Abstract
227 sera from myasthenic patients were tested for the presence of anti-AChR antibodies (anti-AChR Abs) by mean of a fetal calf receptor (Fc-AChR); 73.5% of cases proved positive with this method. Significant correlations were found between presence of anti-Fc-AChr Abs and various clinical aspects such as: clinical stage and duration of disease; moreover significantly higher than the median titers were found among younger patients (i.e. age less than 40 yrs).
Similar articles
-
New antigen for antibody detection in myasthenia gravis.Neurology. 1984 Mar;34(3):374-7. doi: 10.1212/wnl.34.3.374. Neurology. 1984. PMID: 6538281
-
[Antibodies in myasthenia gravis].Rev Neurol (Paris). 2009 Feb;165(2):137-43. doi: 10.1016/j.neurol.2008.11.020. Epub 2009 Jan 21. Rev Neurol (Paris). 2009. PMID: 19162288 Review. French.
-
Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.Neurology. 1980 May;30(5):543-6. doi: 10.1212/wnl.30.5.543. Neurology. 1980. PMID: 7189261
-
Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.J Neurol Neurosurg Psychiatry. 1985 Dec;48(12):1246-52. doi: 10.1136/jnnp.48.12.1246. J Neurol Neurosurg Psychiatry. 1985. PMID: 4087000 Free PMC article.
-
Diagnostics of myasthenic syndromes: detection of anti-AChR and anti-MuSK antibodies.Neurol Sci. 2017 Oct;38(Suppl 2):253-257. doi: 10.1007/s10072-017-3026-2. Neurol Sci. 2017. PMID: 29030770 Review.
Cited by
-
Clinical implementation of anti-acetylcholine receptor antibodies.J Neurol Neurosurg Psychiatry. 1993 May;56(5):496-504. doi: 10.1136/jnnp.56.5.496. J Neurol Neurosurg Psychiatry. 1993. PMID: 8505642 Free PMC article.
-
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.Ann Clin Transl Neurol. 2020 Aug;7(8):1327-1339. doi: 10.1002/acn3.51121. Epub 2020 Jul 22. Ann Clin Transl Neurol. 2020. PMID: 32700461 Free PMC article. Clinical Trial.
-
Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension Study.Front Neurol. 2020 Nov 24;11:556104. doi: 10.3389/fneur.2020.556104. eCollection 2020. Front Neurol. 2020. PMID: 33329303 Free PMC article.
-
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.Muscle Nerve. 2019 Jul;60(1):14-24. doi: 10.1002/mus.26447. Epub 2019 Mar 8. Muscle Nerve. 2019. PMID: 30767274 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical